News & Insights

Vicki Kiesel, CEO and Founder of Genetic Experts, joined BBC Radio Derby’s Becky Measures Show on 16 September 2026 to discuss the psychological impact of genetic testing. Vicki explored the emotional considerations of receiving genetic information and the importance of providing appropriate support alongside genetic testing. Listen to Vicki’s interview from 1:36:00 to 1:45:00 in the programme on BBC Sounds.

Vicki Kiesel joined Leicester’s Community Cancer Health & Wellbeing Event, offering cancer risk assessment and genetic testing advice to visitors: Connecting with the Cancer Community at Leicester’s Biggest Health and Wellbeing Event

Vicki Kiesel joined BBC Radio Derby’s It Starts With You campaign to help raise awareness of inherited cancer risk and the importance of talking openly about family history. At an Age UK event in Derby, Vicki spoke with families about recognising patterns that may suggest hereditary cancer and how genetic counselling can support informed choices about testing, screening and risk management.

Genetic Experts is proud to support BBC Radio Derby’s “It Starts With You” campaign, raising awareness of how family history can help identify inherited cancer risk. Our CEO, Vicki Kiesel, is featured in the campaign and is supporting conversations around genetic risk, early advice and prevention.

Marking South Asian Heritage Month through the lens of genomic medicine, community and inclusive healthcare.

Our Founder and CEO Vicki Kiesel has been nominated for the UHL Compassionate and Inclusive Leader award in recognition of her supportive and inclusive leadership.

Vicki, our CEO & Founder, is delighted to see the UK Cancer Genetics Group's new position statement published following the recent consensus meeting, which she was privileged to contribute to.

The UKCGG consensus statement provides, for the first time, nationally agreed recommendations on when and how healthcare professionals should recontact individuals carrying pathogenic variants in hereditary cancer susceptibility genes.

The ABS–UKCGG–CanGene–CanVar consensus on the use of CanRisk in clinical practice marks an important milestone in the delivery of hereditary cancer risk assessment across the UK.